SEC Form 4 · accession 0001127602-15-011324
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Zaccardelli
Officer — EVP & Chief Operating Officer
Period of report
Mar 13, 2015
Accepted (ET)
Mar 16, 2015 · 7:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking AwardF1 | $163.30 | Mar 13, 2015 | A | 46,500 | A | Mar 13, 2016 | Mar 13, 2025 | Common Stock | 46,500 | 46,500 | D |
Explanation of responses
- F1These share tracking awards vest in one-fourth increments on each of March 13, 2016, 2017, 2018 and 2019, and settle in cash only.